Capital Advisory Group Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-580
| Closed | -$52K | – | 200 |
|
2022
Q2 | $52K | Hold |
580
| – | – | 0.03% | 158 |
|
2022
Q1 | $52K | Buy |
+580
| New | +$52K | 0.02% | 238 |
|
2021
Q4 | – | Sell |
-580
| Closed | -$73K | – | 521 |
|
2021
Q3 | $73K | Hold |
580
| – | – | 0.03% | 249 |
|
2021
Q2 | $79K | Hold |
580
| – | – | 0.03% | 243 |
|
2021
Q1 | $79K | Sell |
580
-50
| -8% | -$6.81K | 0.03% | 222 |
|
2020
Q4 | $89K | Hold |
630
| – | – | 0.04% | 217 |
|
2020
Q3 | $70K | Hold |
630
| – | – | 0.04% | 192 |
|
2020
Q2 | $71K | Buy |
630
+50
| +9% | +$5.64K | 0.04% | 186 |
|
2020
Q1 | $45K | Sell |
580
-25
| -4% | -$1.94K | 0.06% | 115 |
|
2019
Q4 | $58K | Hold |
605
| – | – | 0.03% | 126 |
|
2019
Q3 | $47K | Hold |
605
| – | – | 0.03% | 151 |
|
2019
Q2 | $53K | Hold |
605
| – | – | 0.04% | 150 |
|
2019
Q1 | $56K | Sell |
605
-105
| -15% | -$9.72K | 0.04% | 141 |
|
2018
Q4 | $52K | Hold |
710
| – | – | 0.04% | 135 |
|
2018
Q3 | $68K | Hold |
710
| – | – | 0.05% | 123 |
|
2018
Q2 | $68K | Hold |
710
| – | – | 0.05% | 118 |
|
2018
Q1 | $62K | Buy |
+710
| New | +$62K | 0.05% | 126 |
|